Vutiglabridin

Small moleculeexperimental

Clinical trial activity

7 trials · 9 clinical orgs · 0 marketing orgs

Phase 1
4
Phase 2
3
Phase 3
0
Phase 4
0

Earliest trial started Aug 23, 2018 (NCT04732988)

Timeline

2010s

  1. Jan 1, 2018

    Earliest Phase 1 Sponsor(trial)

2020s

  1. Jan 1, 2022

    Earliest Phase 2 Sponsor(trial)

Indications

Mechanism of action

Chemistry & pharmacology

Loading structure…

SMILES

CCOc1ccc(C2COc3c(ccc4c3CCC(C)(C)O4)C2)c(O)c1
Mol. weight
354.45 g/mol
Lipinski Ro5
Pass
Rule of 3
No
Chirality
Racemic Mixture
Inorganic
No
Polymer
No

Oral

No

Parenteral

No

Topical

No

Sources

Clinical trials

NCT IDPhaseStart dateSponsor(s)
NCT06845553Phase 2Jun 1, 2025Glaceum, Seoul National University
NCT06329141Phase 2Jul 1, 2024Catholic University of Korea, Glaceum, Inje University, Korea University, Kyung Hee University, Sungkyunkwan University, Yonsei University
NCT05310032Phase 1Apr 21, 2022Glaceum, Seoul National University
NCT05197556Phase 2Feb 24, 2022Glaceum, Korea University, Seoul National University, Yonsei University
NCT04703764Phase 1Dec 14, 2020Glaceum, Kyungpook University
NCT04733001Phase 1Jul 12, 2020Glaceum, Seoul National University
NCT04732988Phase 1Aug 23, 2018Glaceum, Kyungpook University, Seoul National University
Showing 7 of 7 trials
Page 1 / 1

Organizations

Research & Development (9)

OrganizationOrg typeTrialsAs lead sponsorPhasesEarliest year
GlaceumFor profit7722018
Seoul National UniversityAcademic/Hospital5022018
Korea UniversityAcademic/Hospital2012022
Kyungpook UniversityAcademic/Hospital2012018
Yonsei UniversityAcademic/Hospital2012022
Catholic University of KoreaAcademic/Hospital1012024
Inje UniversityAcademic/Hospital1012024
Kyung Hee UniversityAcademic/Hospital1012024
Sungkyunkwan UniversityAcademic/Hospital1012024
9 organizations
Page 1 / 1